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Abstract
Cationic liposomes and the complexes they form with DNA (lipoplexes) constitute the most promising alternative to the
use of viral vectors for gene therapy. One of the limitations to their application in vivo, however, is the inhibition of gene
delivery by serum. In a previous study, we demonstrated that transferrin (Tf)-lipoplexes were superior to plain lipoplexes in
transfecting HeLa cells in the presence of high concentrations of serum. With the goal of obtaining efficient gene expression
in vivo, we evaluated the efficacy of Tf-lipoplexes (containing DOTAP and cholesterol) in transfecting primary hepatocytes
and adipocytes in the presence of high serum concentrations. The association of transferrin with cationic liposomes
increased luciferase expression compared to plain lipoplexes in primary cells as well as in HepG2 and 3T3-L1 differentiated
adipocytes. The complexes were not cytotoxic and were highly effective in protecting DNA from attack by DNase I. An
efficient and reliable method was developed to prepare lipoplexes containing both Tf and protamine sulfate, where the
latter was mixed with transferrin, followed by the addition of cationic liposomes and DNA. The resulting protamine-Tf-
lipoplexes increased significantly the levels of gene expression in cultured cells and in various tissues in mice following i.v.
administration. ß 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Cationic liposomes have several advantages over
viral systems as gene delivery vehicles. There are no
size limitations for the construction of vectors, which
makes the introduction of genomic fragments, in-
cluding complex transcriptional control elements,
possible. They act by compacting plasmid DNA,
and mediate cellular uptake primarily via endocytosis
following the interaction of positively charged com-
plexes with negatively charged biological surfaces
[1^4]. One disadvantage of the use of cationic lipo-
somes is the considerable reduction of transfection
e⁄ciency by serum components [5^8]. The inhibitory
e¡ect of serum on transfection mediated by lipo-
plexes has been reported for di¡erent cell lines, in-
cluding hepatocytes [9,10], and represents a serious
limitation for their use in vivo. Thus, during the in
vitro assessment of transfection reagents, it is impor-
tant to emulate in vivo conditions by using high con-
centration of serum, rather than serum-free medium
which usually optimizes gene transfer.
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Hepatocytes and adipocytes, like many other ter-
minally di¡erentiated cells, are relatively resistant to
transfection. It would, therefore, be of interest to
develop systems that enable the e⁄cient transfer of
functional DNA molecules into such cells. Although
several viral vectors including adeno- [11,12] and ret-
roviruses [13,14], and non-viral methods such as elec-
troporation [15], calcium phosphate [16], DEAE-dex-
tran [15], cationic lipids [17,18] and polymer
derivatives [19,20], have been developed to transfect
primary hepatocytes, it is generally di⁄cult to
achieve signi¢cant levels of gene expression without
causing high cytotoxicity [21]. Furthermore, none of
these vectors have been utilized in the presence of
high concentrations of serum. 3T3-L1 adipocytes
have been transfected by adenovirus [22,23], calcium
phosphate [24] and electroporation [25]. Primary adi-
pocytes have also been transfected by electroporation
[26,27] and adenovirus [28], but these techniques
were also often associated with cellular toxicity. So
far, transfection of DNA has not been applied suc-
cessfully in primary adipocytes by non-viral vectors
in the presence of high concentrations of serum.
Receptor-mediated gene delivery methods have
also been explored, using receptor ligands conjugated
to either polycations [29^31] or cationic lipids [32].
The expression of transferrin receptors is particularly
high on proliferating malignant cells, as compared
with the corresponding normal ones, making this re-
ceptor an attractive target for cancer gene therapy
[33,34]. The association of transferrin (Tf) with cat-
ionic liposomes followed by complexation with DNA
has been shown to generate vectors that are far more
e⁄cient in gene transfer than conventional lipoplexes
[4,35^37].
When DNA is administered to the whole body it
could be attacked by nucleases in the blood and/or
cellular lysosomes, and ¢nally degraded. Therefore,
the gene delivery carrier should function as a protec-
tor of the DNA during in vivo administration. Prot-
amine has been shown to cause condensation of
DNA, to promote cellular entry and to potentiate
gene expression by increasing the nuclear transloca-
tion of DNA [38,39]. The use of this polycation
could improve the in vivo activity of lipoplexes
[40,41] and has the additional advantages of being
non-toxic and only weakly immunogenic in humans.
It is important also to note that the way the DNA is
mixed with liposomes to form lipoplexes, as well as
the ¢nal size, a¡ects greatly the e⁄ciency of the re-
sulting complexes [35,42].
In this report, we describe the ability of Tf-lipo-
plexes in enhancing gene expression in primary cells
in the presence of high concentrations of serum. Ad-
ditionally, we have optimized the transfection e⁄-
ciency of these complexes by adding protamine and
designing a new protocol to prepare them. Our re-
sults show that protamine greatly enhances the levels
of transgene expression over the increase observed
with Tf-lipoplexes, and that these vectors are more
e¡ective and less toxic than traditional plain com-
plexes for in vivo systemic administration.
2. Materials and methods
2.1. Materials
The cationic lipid 1,2-dioleoyl-3-(trimethylammo-
nium) propane (DOTAP), dioleoylphosphatidyletha-
nolamine (DOPE) and cholesterol (CHOL) were pur-
chased from Avanti Polar Lipids (Alabaster, AL,
USA). Iron-saturated, heat-inactivated human trans-
ferrin was obtained from Collaborative Biomedical
Products, Becton Dickinson (Bedford, MA, USA).
The plasmids, pCMVLuc (VR-1216) encoding lucif-
erase and pCMVLacZ (Clontech, Palo Alto, CA,
USA) encoding L-galactosidase, were used for carry-
ing out the transfection experiments. NaCl, N-(2-hy-
droxyethyl)piperazine-NP-(2-ethanesulfonic acid)
(HEPES) and protamine sulfate (derived from sal-
mon) were obtained from Sigma (Madrid, Spain).
Alamar blue dye was purchased from Accumed In-
ternational Companies (Westlake, OH, USA), and
DNase I and ethidium bromide from Gibco BRL
Life Technologies (Barcelona, Spain).
2.2. Cell isolation and culture
HepG2 human hepatoblastoma cells (American
Type Culture Collection, Rockville, MD, USA),
were maintained at 37‡C under 5% CO2 in Dulbec-
co’s modi¢ed Eagle’s medium-high glucose
(DMEM), supplemented with 10% (v/v) heat-inacti-
vated fetal bovine serum (FBS), penicillin (100 units/
ml), streptomycin (100 Wg/ml) and L-glutamine
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(4 mM) (Gibco BRL Life Technologies). Cells were
passaged 1:10 by trypsinization once a week.
3T3-L1 cells (American Type Culture Collection),
are a derivative of mouse ¢broblasts, which di¡er-
entiate into an adipocyte-like phenotype under ap-
propriate conditions [43]. Cells were cultured in six-
well plates (35 mm well diameter, Costar, Acton,
MA, USA), in DMEM, containing 10% FBS, peni-
cillin (100 units/ml) and streptomycin (100 Wg/ml).
Con£uent cells were induced to di¡erentiate by incu-
bating for 48 h with di¡erentiation medium contain-
ing 1 WM dexamethasone, 0.5 mM isobutylmethyl-
xanthine (IBMX), 10 Wg/ml insulin and 10% FBS
in DMEM. After this time, cells were maintained
in postdi¡erentiation medium containing 10 Wg/ml
insulin and 10% FBS, which was changed every
2 days. Passages 3^9 were used in all studies. 3T3-
L1 cells were transfected 8 days after the induction of
di¡erentiation.
Primary hepatocytes were isolated from adult male
Wistar rats (250 g) by in situ perfusion of the liver
with collagenase [44], following anesthesia with pen-
tobarbital. As soon as the cells detached from the
capsule of Glisson, the perfusion was stopped and
the liver was removed. The hepatocytes were ¢ltered
through a 100 Wm mesh in order to obtain a single-
cell suspension. Hepatocytes were recovered by low
speed (50Ug) centrifugation and resuspended in
RPMI 1640 (Gibco BRL Life Technologies). When
the viability of the cells, determined by trypan blue
exclusion, was more than 98%, isolated hepatocytes
were utilized in subsequent experiments. Hepatocytes
were plated in type I collagen (Collaborative Bio-
medical Products, Becton Dickinson, Bedford, MA,
USA)-coated six-well plates (35 mm well diameter) at
a density of 106 viable cells per well, and cultured in
RPMI 1640, supplemented with 10% (v/v) heat-inac-
tivated FBS, penicillin (100 units/ml), streptomycin
(100 Wg/ml) and L-glutamine (4 mM). After attach-
ment of the viable cells, non-viable cells were re-
moved by changing the medium. This procedure re-
sulted in a constant cell density at the time of
transfection.
Adipocytes were isolated from epididymal fat pads
of adult male Wistar rats [45]. The fat pads were
minced into pieces in Krebs^Ringer HEPES bu¡er
(pH 7.4; containing 5 mM D-glucose, 2% BSA, 135
mM NaCl, 2.2 mM CaCl2W2H2O, 1.25 mM
MgSO4W7H2O, 0.45 mM KH2PO4, 2.17 mM
Na2HPO4 and 10 mM HEPES). Adipose tissue frag-
ments were digested in the same bu¡er with type I
collagenase (1.25 mg/ml per gram of tissue) at 37‡C
with gentle shaking at 60 cycles/min for 30 min. The
resulting cell suspension was diluted in HEPES-phos-
phate bu¡er and the isolated adipocytes were then
separated from the undigested tissue by ¢ltration
through a 400 Wm nylon mesh and washed three
times. Cells were resuspended in DMEM supple-
mented with 1% FBS and incubated for 30 min at
37‡C. Adipocytes (150 Wl of 2:1 ratio of packed cells
to medium) were then plated on a collagen matrix
(Vitrogen 100, Cohesion, Palo Alto, CA, USA) in
six-well culture plates. After a 45 min incubation at
37‡C, the culture medium was added and the cells
were maintained in an incubator at 37‡C in 5% CO2
for 16^24 h prior to transfection.
2.3. Liposome preparation
DOTAP/DOPE (1:1 molar ratio) liposomes were
prepared by drying a chloroform solution of the lip-
ids by rotary evaporation under reduced pressure
and then by hydrating the ¢lm with 1 ml of deionized
water to a concentration of 5 mg total lipid/ml. The
tube was vortexed for 1 min and the suspension was
diluted to a ¢nal concentration of 1 mg/ml of total
lipid. The resulting multilamellar vesicles were ex-
truded through polycarbonate membranes with 100
nm pore diameter using a Liposofast device (Avestin,
Toronto, ON, Canada), to obtain a uniform size dis-
tribution and ¢lter-sterilized (Millex 0.22 Wm, Milli-
pore, Bedford, MA, USA). DOTAP/CHOL (1:0.9
molar ratio) liposomes used for in vivo studies
were hydrated with a 10 mM HEPES, 10% (w/v)
glucose bu¡er (pH 7.4) to give a ¢nal concentration
of 10 mM DOTAP/9 mM CHOL. The average diam-
eter of the liposomes was 102 þ 10 nm. Liposomes
were stored at 4‡C under nitrogen and were used
within 1 month after preparation.
2.4. Preparation of lipoplexes
Complexes for in vitro experiments were prepared
by ¢rst mixing 400 Wl of a solution of 100 mM NaCl,
20 mM HEPES, pH 7.4, with (Tf-lipoplexes) or with-
out (plain lipoplexes) 128 Wg of transferrin, with 8, 16,
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32 or 64 Wl of the DOTAP/DOPE liposome suspen-
sion and incubating for 15 min at room temperature.
Four hundred microliters of HEPES bu¡er contain-
ing 3.5 Wg of pCMVLuc or pCMVLacZ were then
added and gently mixed. Complexes for in vivo ex-
periments, prepared at a 5/1 (+/3) charge ratio, con-
tained 19 mM of total lipid (DOTAP/CHOL) and 32
Wg of transferrin per Wg of DNA. Protamine-Tf-lipo-
plexes were prepared by two di¡erent protocols: one
involved the precomplexation of plasmid DNA with
protamine followed by the addition of pre-formed
cationic liposome^transferrin complexes, prepared
as described above (protocol 1). The other involved
mixing of transferrin with protamine, followed by
their addition to the liposomes, incubation for 15
min, addition of the plasmid and further incubation
for 15 min (protocol 2). The ¢nal concentration of
plasmid in the complexes was 0.3 mg/ml. The lipid to
DNA charge ratio was calculated as the mole ratio
of DOTAP (one charge per molecule) to nucleotide
residue (average MW 330).
2.5. Cell culture transfections
For transfection, cells were seeded in 2 ml of me-
dium in six-well culture plates (35 mm well diameter,
Costar), 24 h before addition of the complexes. Cells
were washed twice with DMEM or RPMI without
antibiotics and then 1.2 ml of fetal bovine serum and
0.8 ml of complexes were added gently to each well.
After a 4 h incubation in 60% FBS (at 37‡C in 5%
CO2) the medium was replaced, and the cells were
further incubated for 48 h in medium containing 10%
FBS. It should be noted that in all our experiments
the number of viable cells plated and the cell density
at the moment of transfection were constant.
2.6. In vitro transfection activity
After 48 h, cells were washed with phosphate-bu¡-
ered saline (PBS) and lysed using 250 Wl of reporter
lysis bu¡er (Promega, Madison, WI, USA) at room
temperature for 10 min, followed by two alternating
freeze^thaw cycles. The cell lysate was centrifuged
for 2 min at 12 000Ug to pellet debris. Twenty mi-
croliters of the supernatant were assayed for total
luciferase activity using the luciferase assay reagent
(Promega), according to the manufacturer’s protocol.
A luminometer (Sirius-2, Berthold Detection Sys-
tems, Innogenetics, Diagno¤stica y Terape¤utica, Bar-
celona, Spain) was used to measure luciferase activ-
ity. The protein content of the lysates was measured
by the DC Protein Assay reagent (Bio-Rad, Her-
cules, CA, USA) using bovine serum albumin as
the standard. The data were expressed as pg or ng
of luciferase (based on a standard curve for luciferase
activity) per mg of protein.
2.7. Transfection e⁄ciency
Transfection e⁄ciency was evaluated by scoring
the percentage of cells expressing L-galactosidase.
Cells transfected with 3.5 Wg of pCMVLacZ were
washed with PBS, ¢xed in a solution of 2% form-
aldehyde and 0.2% glutaraldehyde and stained with a
solution containing X-gal (5-bromo-4-chloro-3-indol-
yl-L-D-galactopyranoside) (1 mg/ml). The cells were
incubated at 37‡C for 12 h and examined under a
phase contrast microscope for the development of
blue color. Quanti¢cation of transfected cells was
performed by counting the number of stained and
unstained cells in about 20 randomly selected
¢elds.
2.8. Cell viability assay
Cell viability was quanti¢ed by a modi¢ed Alamar
blue assay [46,47]. Brie£y, 2 ml of 10% (v/v) Alamar
blue dye in DME-HG supplemented with 10% (v/v)
FBS medium were added to each well 48 h after
transfection. After 2.5 h of incubation at 37‡C, 200
Wl of the supernatant was assayed by measuring the
absorbance at 570 and 600 nm. Cell viability (as a
percentage of control cells) was calculated according
to the formula (A5703A600) of treated cellsU100/
(A5703A600) of control cells.
2.9. DNase I protection assays
Tf-lipoplexes at di¡erent charge ratios were pre-
pared as described above. DNase I (1 unit per Wg
of DNA) was added to 2.5 Wg (DNA) of each sample
and the mixtures were incubated at 37‡C for 30 min.
Sodium dodecyl sulfate (SDS) was then included to a
¢nal concentration of 1% to release DNA from the
complexes. Samples were analyzed by agarose gel
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electrophoresis and the integrity of the plasmid in
each formulation was compared with untreated
DNA as a control. UV spectroscopic studies were
performed with a reaction mixture containing 5 Wg/
ml of plasmid DNA. After a 15 min incubation of
Tf-lipoplexes at room temperature, 1 unit of DNase I
per Wg of DNA was added and the absorbance was
monitored at 20 s intervals for 30 min in a UV spec-
trophotometer (Hewlett-Packard 8452 A, Wald-
bronn, Germany).
2.10. Dye displacement assay
The binding of protamine to DNA inside Tf-lipo-
plexes was examined using a quenching method
based on ethidium bromide, a monovalent DNA-in-
tercalating agent which occupies an e¡ective binding
site of two base pairs; its £uorescence is dramatically
enhanced upon binding to DNA and quenched when
displaced by higher a⁄nity compounds or by con-
densation of the DNA structure. Brie£y, 12 Wg of
DNA in 2 ml of 10 mM HEPES, 10% (w/v) glucose
bu¡er (pH 7.4) were mixed with 1.4 Wg of ethidium
bromide and a baseline £uorescence (F0) was deter-
mined. Various amounts of protamine were added to
the above mixture followed by cationic lipids and
transferrin in order to prepare 4/1 (+/3) charge ratio
Tf-lipoplexes. The £uorescence was measured (n = 3)
after each addition in an LS 50 spectro£uorimeter
(Perkin-Elmer, Mountain View, CA, USA), at an
excitation and emission wavelength of 520 and 600
nm, respectively, with a slit width of 6 mm. The rel-
ative £uorescence values were determined as follows:
Fr = (Fobs3Fe)U100/(F03Fe), where Fr is the relative
£uorescence, Fobs is the measured £uorescence, Fe is
the £uorescence of ethidium bromide in the absence
of DNA under the given bu¡er conditions, and F0 is
the initial £uorescence of ethidium bromide-DNA in
the absence of the lipid and the polycation.
2.11. In vivo gene expression
Female Balb-c mice (8^10 weeks of age), pur-
chased from Harlan Ibe¤rica Laboratories (Barcelona,
Spain), and housed in accordance with institutional
guidelines, were used for the experiments. Individual
mice in groups of eight were injected via the tail vein
with 60 Wg of DNA formulated in plain, Tf- or prot-
amine-Tf-lipoplexes in a total volume of 200 Wl 5%
w/v glucose. Twelve hours following i.v. injection,
the mice were sacri¢ced with a sodium pentobarbital
overdose and approx. 1 ml of blood was removed by
intracardiac puncture. One milliliter of PBS was per-
fused through the right cardiac ventricle. The heart,
lungs, liver and spleen were collected and washed
with cold saline twice. The organs were homogenized
with lysis bu¡er (Promega) using a homogenizer
(Mini-Beadbeater, BioSpec Products, Bartlesville,
OK, USA) and centrifuged at 12 000Ug for 3 min
at 4‡C. Twenty microliters of the supernatant were
analyzed for luciferase activity as described previ-
ously.
2.12. Particle size and j potential measurements
The particle size of complexes was measured by
dynamic light scattering, and the overall charge by
j potential measurements, using a particle analyzer
(Zetamaster, Malvern Instruments, Spain). Samples
of the prepared complexes (2.5 ml) were measured
three times for 60 s at 1000 Hz and an electric cur-
rent of 3 mA with zero ¢eld correction.
3. Results
3.1. Transfection activity in HepG2 and 3T3-L1 cells
by plain and Tf-lipoplexes
Transfection mediated by either plain or Tf-lipo-
plexes at di¡erent lipid/DNA (+/3) charge ratios
was examined in the presence of 60% FBS. Transfec-
tion activity in hepatic cells (HepG2) with complexes
containing transferrin at 1/2, 1/1, 2/1 and 4/1 (+/3)
charge ratios was respectively 160-, 500-, 130- and 6-
fold higher than that obtained with plain lipoplexes.
The transfection activity of Tf-lipoplexes increased as
the charge ratio of complexes was increased (Fig. 1).
Luciferase gene expression in 3T3-L1 di¡erentiated
adipocytes transfected with Tf-lipoplexes was at least
20-fold higher than transfections performed with
plain lipoplexes. The greatest enhancement over plain
lipoplexes was observed in the case of 1/2 (+/3) com-
plexes (200-fold). The 4/1 (+/3) complexes produced
the highest activity (Fig. 2). No gene expression was
detected with the naked plasmid with either cell line.
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3.2. Transfection of primary cells
Although non-dividing cells are known to be di⁄-
cult to transfect, the association of transferrin with
cationic liposomes also increased luciferase expres-
sion compared to plain complexes in primary culture
rat hepatocytes (Fig. 3) and adipocytes (Fig. 4).
Compared to plain lipoplexes, luciferase expression
mediated by Tf-lipoplexes in primary hepatocytes
was approx. 5^40-fold higher depending on the
charge ratio used. In primary adipocytes luciferase
activity was 4^5-fold higher than that obtained by
plain lipoplexes. Transfection also increased with in-
creasing charge ratio (+/3) of lipid to DNA in the
complex and was much higher than that obtained
with the naked plasmid.
To investigate whether the enhancement of trans-
Fig. 4. Transfection of primary adipocytes with plain and Tf-
lipoplexes. The data represent the mean þ S.D. of three wells
and are representative of three independent experiments.
Fig. 3. Transfection of primary hepatocytes by plain and Tf-
lipoplexes. The data represent the mean þ S.D. of three wells
and are representative of three independent experiments.
Fig. 2. Transfection activity of plain and Tf-DOTAP/DOPE
lipoplexes in 3T3-L1 cells. The data represent the mean þ S.D.
of three wells and are representative of three independent ex-
periments.
Fig. 1. Transfection of HepG2 cells by plain and Tf-DOTAP/
DOPE lipoplexes. The data represent the mean þ S.D. of three
wells and are representative of three independent experiments.
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fection mediated by the association of transferrin in
the presence of serum was only due to an enhance-
ment of gene expression or also due to an increase in
the number of primary cells transfected, we evaluated
the transfection e⁄ciency, de¢ned as the percentage
of cells that visibly express the L-galactosidase gene.
Transfection e⁄ciency of primary hepatocytes by Tf-
lipoplexes in the presence of 60% FBS was maximal
for the 4/1 (+/3) charge ratio. The number of blue
cells when Tf-lipoplexes were used was always higher
than that obtained with plain lipoplexes (Table 1).
No blue cells were detected when naked plasmid
was transfected.
3.3. Cytotoxicity
Cell viability following transfection was assessed to
evaluate whether transferrin and plain complexes at
various lipid/DNA (+/3) charge ratios were toxic to
the cells. The Alamar blue assay showed a viability
higher than 90% in HepG2 as well as in primary
hepatocytes (Fig. 5). The relative cytotoxicity of lipo-
plexes was also assessed by the total amount of ex-
tractable cellular proteins in the cell lysate per well,
and con¢rmed the results with the Alamar blue assay
(data not shown).
3.4. Nuclease resistance of Tf-lipoplexes
To assess the role of our complexes in protecting
the DNA from attack by degrading enzymes in
vivo, an in vitro DNase I protection assay was per-
formed with Tf-lipoplexes prepared at di¡erent
charge ratios. The gel electrophoresis data are
shown in Fig. 6A. Protection of DNA increased
by increasing the charge ratio in the complex, and
resulted to be, by measuring the intensity of the
bands compared to untreated plasmid (100%) (lane
1), about 90% for complexes prepared at 4/1 (+/3)
charge ratio (lane 6). Free DNA was completely
degraded (lane 2).
Stabilization of DNA in Tf-lipoplexes was further
studied by UV spectroscopy (Fig. 6B). By addition
of DNase I to native DNA, absorbance of the so-
lution was increased immediately due to the frag-
mentation of the plasmid. Almost 100% of the sub-
strate was degraded within 4 min. On the other
hand, DNA complexed with Tf-lipoplexes at maxi-
mal charge ratios, 2/1 and 4/1 (+/3), was completely
protected, showing almost no increase in absor-
bance at 260 nm.
3.5. E¡ect of protamine sulfate on in vitro transfection
by Tf-lipoplexes
Fig. 7 shows a dose-dependent gene expression by
protamine included in Tf-lipoplexes compared to
plain and Tf-complexes in the absence of the poly-
cation. Maximum level of transfection was observed
at the protamine concentration of 0.5 Wg per Wg of
DNA, and was 9-fold over Tf-lipoplexes and 25-fold
Fig. 5. E¡ect of plain (P) and transferrin (Tf)-lipoplexes on the
viability of HepG2 cells and primary hepatocytes. Data repre-
sent the mean þ S.D. obtained from duplicate wells and are rep-
resentative of two independent experiments.
Table 1
Gene transfer e⁄ciency (% of blue cells) in primary hepatocytes
by plain (DOTAP/DOPE) and Tf-lipoplexes containing
pCMVLacZ in the presence of 60% serum
Charge ratio (+/3) Plain lipoplexes Tf-lipoplexes
0.5 1^2 2^4
1 1^2 3^5
2 1^2 6^7
4 2^3 8^10
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over the levels seen with plain complexes. The poly-
cation itself in combination with DNA had no sig-
ni¢cant e¡ect on gene expression. Fig. 7 also shows
the in£uence of preparing the complexes by the
newly designed method (protocol 2), by which the
highest level of transfection was obtained. An 18-
fold increase over Tf-lipoplexes without protamine
and a 2-fold increase over protamine-Tf-lipoplexes
prepared by the conventional method (protocol 1)
were observed.
3.6. Displacement of intercalated ethidium bromide by
protamine inside Tf-lipoplexes: DNA binding
assay
The displacement of ethidium bromide from DNA
in Tf-lipoplexes was monitored by measuring the
£uorescence as protamine sulfate was added to the
complexes. The addition of the polycation resulted in
a rapid decrease in £uorescence. At the optimal
amount of protamine obtained for in vitro studies
(0.5 Wg), DNA was almost completely condensed in-
side the Tf-lipoplexes at the 4/1 (+/3) charge ratio
(Fig. 8). The residual £uorescence (Fres), at which the
polycation can no further exclude ethidium bromide
from the DNA, had a low value of 1.9.
3.7. In vivo gene expression of
protamine-Tf-lipoplexes
Finally, to test whether Tf-lipoplexes and prot-
amine-Tf-lipoplexes could be used for in vivo gene
delivery, complexes were injected systemically into
mice and their activity was compared to plain lipo-
plexes. Fig. 9 shows that complexes in the presence
of the ligand lead to a higher level of gene expres-
sion compared to plain lipoplexes in the four
Fig. 7. Gene expression in HepG2 cells by plain (white bars)
and Tf-lipoplexes (gray bars, protocol 1; black bars, protocol
2) in the absence or presence of protamine sulfate. Complexes
were prepared at 4/1 (+/3) charge ratio. The data represent the
mean þ S.D. of three wells and are representative of three inde-
pendent experiments.
Fig. 6. (A) Susceptibility of plasmid DNA or Tf-lipid/DNA
complexes to degradation by DNase I treatment. Untreated
DNA (lane 1), DNA treated with DNase: naked plasmid (lane
2), DNA inside Tf-lipoplexes at 1/2 (lane 3), 1/1 (lane 4), 2/1
(lane 5) and 4/1 (lane 6) (+/3) charge ratios. (B) Degradation
pro¢le of DNA alone or Tf-lipid/DNA complexes at 2/1 and
4/1 (+/3) charge ratios with DNase I.
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studied organs. Protamine-Tf-lipoplexes, prepared
by the newly developed protocol, resulted in an
increase of 5-, 2-, 1.3- and 5-fold in the liver,
lung, heart and spleen respectively, over Tf-lipo-
plexes.
3.8. Determination of particle size and j potential of
complexes
The diameters of plain, Tf- and protamine-Tf-lipo-
plexes, used for in vivo studies, were 230, 388 and
200 nm respectively while the surface charges were
36, 16 and 20 mV respectively. Addition of prot-
amine to the complex led to a signi¢cant decrease
in the particle size compared to Tf-lipoplexes.
4. Discussion
Since lipoplex-mediated transfection of many cell
types is inhibited by serum [5,48,49], most in vitro
transfection studies in the literature have been car-
ried out in the absence of serum or in the presence of
at most 20% serum. It is interesting to note that in
this study, all the experiments were performed in the
presence of 60% FBS, following the optimal condi-
tions reported in our previous work [7]. The results
shown in Figs. 1 and 2 demonstrate that Tf-lipo-
plexes mediate higher gene expression in HepG2
and 3T3-L1 cells compared to plain lipoplexes. The
maximal activity is observed for Tf-complexes at the
4/1 (+/3) charge ratio. One possible explanation for
Fig. 9. In vivo transfection e⁄ciency of plain (white bars), Tf-lipoplexes (gray bars) and protamine-Tf-lipoplexes (black bars). Com-
plexes in the presence of the polycation were prepared with 0.5 Wg of protamine per Wg of DNA following protocol 2, as described in
Section 2. The results are expressed as pg of luciferase per mg of protein (n = 8).
Fig. 8. Binding behavior of protamine to DNA, studied by
ethidium bromide assay. Complexes were prepared at 4/1 (+/3)
lipid to DNA charge ratio. Each point represents the mean of
three replicate measurements.
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this enhancement is that non-speci¢c interactions of
plain lipoplexes with negatively charged macromole-
cules in serum most likely prevent their binding to
the cells, while Tf-lipoplexes can interact with cell
surface receptors. Also, the charge neutralizing e¡ect
of the negatively charged macromolecules present in
serum is countered by an excess of positive charge on
the Tf-lipoplexes.
Hepatocytes and adipocytes, like many other ter-
minally di¡erentiated cells, are relatively resistant to
transfection. The development of a system that ena-
bles the e⁄cient transfer of functional DNA mole-
cules to such cells was one of the aims of this study.
The same behavior observed in the cell lines was
observed in primary hepatocytes and adipocytes, as
shown in Figs. 3 and 4. Tf-lipoplexes gave always
higher levels of transfection compared to plain lipo-
plexes. Association of Tf with the liposomes appears
to facilitate the internalization of the complexes due
to the ability of the ligand to stimulate endocytosis
[50]. Although the highest level of gene expression
was reached with positively charged complexes, it
should be noted that the maximum fold increase
over plain lipoplexes was achieved with neutral 1/1
and negatively charged 1/2 (+/3) lipoplexes, which
remained e¡ective despite any possible interaction
with serum components. No measurable luciferase
expression was observed with DNA alone either in
the cell lines or in primary hepatocytes and adipo-
cytes.
The correlation between transfection activity and
e⁄ciency, observed by the L-gal assay in primary
hepatocytes (Table 1), indicated that not only is
gene expression higher by using Tf-lipoplexes, but
also the number of transfected cells. Conditions
which enhance transfection activity also enhance
transfection e⁄ciency, although the percentage of
enhancement cannot be correlated directly. It is
also interesting to note that none of the complexes
used in this study were toxic to the cells, concluded
from the viability assay (Fig. 5).
Another possible mechanism for the enhancement
in transfection by Tf-lipoplexes includes improved
protection of DNA inside the complexes, as is shown
in the protective ability assays (Fig. 6). Gel electro-
phoresis data showed the high level of nuclease re-
sistance for DNA formulated in Tf-lipoplexes, which
con¢rms its stable nature. At the 4/1 (+/3) charge
ratio, the plasmid is almost completely protected
from digestion by DNase I (Fig. 6A, lane 6). UV
spectroscopy data con¢rmed the preceding results.
When DNA itself was treated with DNase I under
physiological conditions, complete degradation oc-
curred within 4 min; however, the percentage of de-
graded plasmid in Tf-lipoplexes at this time, for the
maximal charge ratio, was only 7% of that for native
DNA (Fig. 6B). This feature of high resistance to-
ward nuclease attack is surely an advantage of using
the Tf^lipid complexes as a reservoir for DNA under
physiological circumstances, when DNA degradation
through nuclease attack takes place readily.
Although protamine has already been proposed to
increase lipid-mediated gene transfection by condens-
ing DNA into a compact structure, which promotes
cellular entry and stability of DNA [38,39,51], one of
the aims of this work was to study the role of prot-
amine in combination with Tf to develop improved
Tf-lipoplexes for in vivo gene delivery. Traditional
protocols for preparing protamine-lipoplexes in-
volves precomplexation of plasmid DNA with prot-
amine, followed by the addition of liposomes. Under
these conditions, however, large amounts of excess
cationic lipids are required to achieve a maximal lev-
el of gene expression. Moreover, the charge neutral-
izing e¡ect of protamine on DNA makes preparation
of complexes di⁄cult at high concentrations, espe-
cially when a high protamine/DNA ratio is required.
Taking this into consideration, we hypothesized that
precomplexing protamine with Tf (slightly negatively
charged), before addition of the plasmid, more stable
complexes could be prepared for in vivo application.
The results presented in Figs. 7 and 9 con¢rmed our
hypothesis, showing the ability of protamine to in-
crease transfection by Tf-lipoplexes in vitro and in
vivo. This enhancement was maximal when com-
plexes were prepared with the new protocol 2, de-
scribed in Section 2. On the other hand, the displace-
ment of intercalated ethidium bromide shown in Fig.
8 demonstrates that, at the optimal amount of prot-
amine needed for in vitro transfection, DNA is al-
most completely condensed. The low value of the
residual £uorescence indicates the e⁄ciency by which
the polycation has condensed the DNA, which is
indicative of the stability of the complex.
In vivo results showed an increase in transfection
by protamine-Tf-lipoplexes over plain complexes,
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which were 11-, 2-, 2- and 12-fold for the liver, lung,
heart and spleen, respectively. Gene expression in the
lung was signi¢cantly higher than that found in other
tissues, as expected from previous studies, in which
the level of transgene expression was approx. 10 ng
luciferase/mg protein [40]. The capacity of transferrin
to promote cellular entry, and the ability of prot-
amine to facilitate nuclear localization of DNA,
could be additional factors that cause enhanced
gene expression. Complexation of Tf with the cation-
ic liposomes could result in charge shielding, as well
as provide steric hindrance to other serum compo-
nents, thereby minimizing the inhibitory e¡ects of
serum.
The smaller particle size of the protamine-Tf-lipo-
plexes can also contribute to the higher gene expres-
sion observed. Continuous increase in the dose of
protamine was not associated with a further increase
in the levels of expression, as shown in Fig. 7, prob-
ably due to charge neutralization of the DNA by
protamine which limits the complexation of DNA
with cationic liposomes.
By using the new protocol, the competition be-
tween cationic liposomes and protamine for interac-
tion with plasmid DNA is greatly reduced. Prot-
amine maintains its ability to condense the DNA
without reducing further interactions with the cation-
ic lipids. Also, lipid and DNA can interact with each
other inside our Tf-lipoplexes in the presence of se-
rum, to form a new structure which is much more
e⁄cient in transfection in vivo. Moreover, although
charge ratios (+/3) close to 10 are used generally for
in vivo transfections, protamine-Tf-lipoplexes at 5/1
(+/3) were able to give e⁄cient gene expression.
Consequently, a reduction in lipid-induced cellular
toxicity compared to plain lipoplexes was observed.
Two of the eight mice died of toxicity when using
plain lipoplexes; yet no signs of toxicity were noticed
when protamine-Tf-lipoplexes were injected.
Our levels of transfection activity showed an im-
provement over the values given by transfection with
other lipoplexes. For example, maximal values ob-
tained by Li and coworkers [41] were in the range
of 0.088^0.88 ng luciferase/mg protein, based on a
conversion of their RLU values to ng luciferase.
The lung levels obtained by Thierry et al. [52] with
a comparable amount of DNA were less than 1 pg/
mg. Luciferase gene expression in the lungs, follow-
ing the administration of targeted adenovirus [53],
was much lower than the RLU/mg values reported
by Li et al. [41] and corresponding ng/mg values
obtained in our experiments. Gene expression in
the liver and spleen, however, was much greater
with the adenoviral vector than with the protamine-
Tf-lipoplexes. We should note that in this study our
goal was not to achieve the highest level of trans-
fection in vivo, but to compare the protamine-Tf-
lipoplexes with plain and Tf-lipoplexes.
In summary, the novel protamine-Tf-lipoplex gene
carrier developed in this study was shown to generate
nanometer-sized particles with plasmid DNA and to
e¡ectively protect the DNA to be delivered to cells.
The carrier had a markedly low toxicity and good
transfection performance in vitro and in vivo. More-
over, it has the advantages of ease of preparation,
and economy in comparison with commercial trans-
fection reagents. Consequently, it could be used
widely for gene transfection into animal cells.
Acknowledgements
We gratefully acknowledge Dr. Mato’s Lab (Uni-
versity of Navarra) for help with the isolation of he-
patocytes. This work was supported by a grant from
the Government of Navarra (Department of Educa-
tion) and funds from the University of Navarra.
References
[1] P.L. Felgner, T.R. Gadek, M. Holm, R. Roman, H.W.
Chan, M. Wenz, J.P. Northrop, G.M. Ringold, M. Daniel-
sen, Lipofection: a highly e⁄cient, lipid-mediated DNA-
transfection procedure, Proc. Natl. Acad. Sci. USA 84
(1987) 7413^7417.
[2] J. Zabner, A.J. Fasbender, T. Moninger, K.A. Poellinger,
M.J. Welsh, Cellular and molecular barriers to gene transfer
by a cationic lipid, J. Biol. Chem. 270 (1995) 18997^19007.
[3] X. Gao, L. Huang, Cationic liposome-mediated gene trans-
fer, Gene Ther. 2 (1995) 710^722.
[4] S. Simo‹es, P. Pires, N. Du«zgu«nes°, M.C. Pedroso de Lima,
Cationic liposomes as gene transfer vectors: barriers to suc-
cessful application in gene therapy, Curr. Opin. Mol. Ther. 1
(1999) 147^157.
[5] V. Ciccarone, P. Hawley-Nelson, J. Jessee, Cationic lipo-
some-mediated transfection: e¡ect of serum on expression
and e⁄ciency, Focus 15 (1993) 80^83.
BBAMEM 78228 26-4-02
C. Tros de Ilarduya et al. / Biochimica et Biophysica Acta 1561 (2002) 209^221 219
[6] K. Crook, B.J. Stevenson, M. Dubouchet, D.J. Porteous,
Inclusion of cholesterol in DOTAP transfection complexes
increases the delivery of DNA to cells in vitro in the presence
of serum, Gene Ther. 5 (1998) 137^143.
[7] C. Tros de Ilarduya, N. Du«zgu«nes°, E⁄cient gene transfer by
transferrin lipoplexes in the presence of serum, Biochim. Bio-
phys. Acta 1463 (2000) 333^342.
[8] V. Escriou, C. Ciolina, F. Lacroix, G. Byk, D. Scherman, P.
Wils, Cationic lipid-mediated gene transfer: e¡ect of serum
on cellular uptake and intracellular fate of lipopolyamine/
DNA complexes, Biochim. Biophys. Acta 1368 (1998) 276^
288.
[9] W.R. Jarnagin, R.J. Debs, S. Wang, D.M. Bissell, Cationic
lipid-mediated transfection of liver cells in primary culture,
Nucleic Acids Res. 20 (1992) 4205^4211.
[10] O. Zelphati, L.S. Uyechi, L.G. Barron, F.C. Szoka Jr., E¡ect
of serum components on the physico-chemical properties of
cationic lipid/oligonucleotide complexes and on their inter-
actions with cells, Biochim. Biophys. Acta 1390 (1998) 119^
133.
[11] R.T. Villavicencio, S. Liu, M.R. Kibbe, D.L. Williams, R.W.
Ganster, K.F. Dyer, D.J. Tweardy, T.R. Billiar, B.R. Pitt,
Induced nitric oxide inhibits IL-6-induced stat3 activation
and type II acute phase mRNA expression, Shock 13
(2000) 441^445.
[12] M.A. Morsy, E.L. Alford, A. Bett, F.L. Graham, C.T. Cas-
key, E⁄cient adenoviral-mediated ornithine transcarbamy-
lase expression in de¢cient mouse and human hepatocytes,
J. Clin. Invest. 92 (1993) 1580^1586.
[13] R.M. Adams, H.E. Soriano, M. Wang, G. Darlington, D.
Ste¡en, F.D. Ledley, Transduction of primary human hepa-
tocytes with amphotropic and xenotropic retroviral vectors,
Proc. Natl. Acad. Sci. USA 89 (1992) 8981^8985.
[14] M. Grompe, S.N. Jones, H. Loulseged, C.T. Caskey, Retro-
viral-mediated gene transfer of human ornithine transcarba-
mylase into primary hepatocytes of spf and spf-ash mice,
Hum. Gene Ther. 3 (1992) 35^44.
[15] R. Tur-Kaspa, L. Teicher, B.J. Levine, A.I. Skoultchi, D.A.
Shafritz, Use of electroporation to introduce biologically ac-
tive foreign genes into primary rat hepatocytes, Mol. Cell.
Biol. 6 (1986) 716^718.
[16] F. Gaunitz, M. Papke, R. Gebhardt, Transient transfection
of primary cultured hepatocytes using CaPO4/DNA precip-
itation, BioTechniques 20 (1996) 826^830.
[17] T. Hara, H. Kuwasawa, Y. Aramaki, S. Takada, K. Koike,
K. Ishidate, H. Kato, S. Tsuchiya, E¡ects of fusogenic and
DNA-binding amphiphilic compounds on the receptor-medi-
ated gene transfer into hepatic cells by asialofetuin-labeled
liposomes, Biochim. Biophys. Acta 1278 (1996) 51^58.
[18] M. Wilke, A. Bijma, A.J. Timmers-Reker, B.J. Scholte, M.
Sinaasappel, Complementation of the genetic defect in gunn
rat hepatocytes in vitro by highly e⁄cient gene transfer with
cationic liposomes, Gene Ther. 4 (1997) 1305^1312.
[19] I. Chemin, D. Moradpour, S. Wieland, W.B. O¡ensperger,
E. Walter, J.P. Behr, H.E. Blum, Liver-directed gene trans-
fer: a linear polyethylenimine derivative mediates highly ef-
¢cient DNA delivery to primary hepatocytes in vitro and in
vivo, J. Viral Hepatol. 5 (1998) 369^375.
[20] P. Bandyopadhyay, B.T. Kren, X. Ma, C.J. Steer, Enhanced
gene transfer into HuH-7 cells and primary rat hepatocytes
using targeted liposomes and polyethylenimine, BioTechni-
ques 25 (1998) 282^292.
[21] F. Ginot, J.F. Decaux, M. Cognet, T. Berbar, F. Levrat, A.
Kahn, A. Weber, Transfection of hepatic genes into adult rat
hepatocytes in primary culture and their tissue-speci¢c ex-
pression, Eur. J. Biochem. 180 (1989) 289^294.
[22] H. Sakaue, W. Ogawa, M. Matsumoto, S. Kuroda, M. Ta-
kata, T. Sugimoto, B.M. Spiegelman, M. Kasuga, Posttran-
scriptional control of adipocyte di¡erentiation through acti-
vation of phosphoinositide 3-kinase, J. Biol. Chem. 273
(1998) 28945^28952.
[23] C.L. Venable, E.U. Frevert, Y.B. Kim, B.M. Fischer, S.
Kamatkar, B.G. Neel, B.B. Kahn, Overexpression of pro-
tein-tyrosine phosphatase-1B in adipocytes inhibits insulin-
stimulated phosphoinositide 3-kinase activity without alter-
ing glucose transport or Akt/protein kinase B activation,
J. Biol. Chem. 275 (2000) 18318^18326.
[24] D. Wang, H.S. Sul, Upstream stimulatory factor binding to
the E-box at 365 is required for insulin regulation of the
fatty acid synthase promoter, J. Biol. Chem. 272 (1997)
26367^26374.
[25] M. Standaert, G. Bandyopadhyay, L. Galloway, Y. Ono, H.
Mukai, R. Farese, Comparative e¡ects of GTP-gammaS and
insulin on the activation of Rho, phosphatidylinositol 3-ki-
nase and protein kinase N in rat adipocytes. Relationship to
glucose transport, J. Biol. Chem. 273 (1998) 7470^7477.
[26] H. Chen, S.J. Wertheimer, C.H. Lin, S.L. Katz, K.E. Am-
rein, P. Burn, M.J. Quon, Protein-tyrosine phosphatases
PTP1B and syp are modulators of insulin-stimulated trans-
location of GLU4 transfected rat adipose cells, J. Biol.
Chem. 272 (1997) 8026^8031.
[27] H. Al-Hasani, C. Hinck, S. Cushman, Endocytosis of the
glucose transporter GLUT4 is mediated by the GTPase dy-
namin, J. Biol. Chem. 273 (1998) 17504^17510.
[28] A.V. Hertzel, M.A. Sanders, D.A. Bernlohr, Adenovirus-
mediated gene transfer in primary murine adipocytes, J. Lip-
id Res. 41 (2000) 1082^1086.
[29] E. Wagner, M. Zenke, M. Cotten, H. Beug, M.L. Birnstiel,
Transferrin-polycation conjugates as carriers for DNA up-
take into cells, Proc. Natl. Acad. Sci. USA 87 (1990) 3410^
3414.
[30] M.M. O’Neill, C.A. Kennedy, R.W. Barton, R.J. Tatake,
Receptor-mediated gene delivery to human peripheral blood
mononuclear cells using anti-CD3 antibody coupled to poly-
ethylenimine, Gene Ther. 8 (2001) 362^368.
[31] R. Kircheis, T. Blessing, S. Brunner, L. Wightman, E. Wag-
ner, Tumor targeting with surface-shielded ligand-polycation
DNA complexes, J. Control. Release 72 (2001) 165^170.
[32] T. Hara, Y. Aramaki, S. Takada, K. Koike, S. Tsuchiya,
Receptor-mediated transfer of pSV2CAT DNA to a human
hepatoblastoma cell line HepG2 using asialofetuin-labeled
cationic liposomes, Gene 159 (1995) 167^174.
BBAMEM 78228 26-4-02
C. Tros de Ilarduya et al. / Biochimica et Biophysica Acta 1561 (2002) 209^221220
[33] L. Xuo, K.F. Pirollo, W.H. Tang, A. Rait, E.H. Chang,
Transferrin-liposome-mediated systemic p53 gene therapy
in combination with radiation results in regression of human
head and neck cancer xenografts, Hum. Gene Ther. 10
(1999) 2941^2952.
[34] R. Kircheis, L. Wightman, A. Schreiber, B. Robitza, V.
Rossler, M. Kursa, E. Wagner, Polyethylenimine/DNA
complexes shielded by transferrin target gene expression
to tumors after systemic application, Gene Ther. 8 (2001)
28^40.
[35] P.W. Cheng, Receptor ligand-facilitated gene transfer: en-
hancement of liposome-mediated gene transfer and expres-
sion by transferrin, Hum. Gene Ther. 7 (1996) 275^282.
[36] S. Simo‹es, V. Slepushkin, R. Gaspar, M.C. Pedroso de
Lima, N. Du«zgu«nes°, Gene delivery by negatively charged
ternary complexes of DNA, cationic liposomes and trans-
ferrin or fusogenic peptides, Gene Ther. 5 (1998) 955^
964.
[37] S. Simo‹es, V. Slepushkin, E. Pretzer, P. Dazin, R. Gaspar,
M.C. Pedroso de Lima, N. Du«zgu«nes°, Transfection of hu-
man macrophages by lipoplexes via the combined use of
transferrin and pH-sensitive peptides, J. Leukocyte Biol. 65
(1999) 270^279.
[38] F.L. Sorgi, S. Bhattacharya, L. Huang, Protamine sulfate
enhances lipid-mediated gene transfer, Gene Ther. 4 (1997)
961^968.
[39] X. Gao, L. Huang, Potentiation of cationic liposome-medi-
ated gene delivery by polycations, Biochemistry 35 (1996)
1027^1036.
[40] S. Li, L. Huang, In vivo gene transfer via intravenous ad-
ministration of cationic lipid-protamine-DNA (LPD) com-
plexes, Gene Ther. 4 (1997) 891^900.
[41] S. Li, M.A. Rizzo, S. Bhattacharya, L. Huang, Character-
ization of cationic lipid-protamine-DNA (LPD) complexes
for intravenous gene delivery, Gene Ther. 5 (1998) 930^937.
[42] O. Boussif, M.A. Zanta, J.P. Behr, Optimized galenics im-
prove in vitro gene transfer with cationic molecules up to
1000-fold, Gene Ther. 3 (1996) 1074^1080.
[43] H. Green, O. Kehinde, Formation of normally di¡erentiated
subcutaneous fat pads by an established preadipose cell line,
J. Cell. Physiol. 101 (1979) 169^171.
[44] H.L. Le¡ert, K.S. Koch, T. Moran, M. Williams, Liver cells,
Methods Enzymol. 58 (1979) 536^544.
[45] W.M. Mueller, F.M. Gregoire, K.L. Stanhope, C.V. Mobbs,
T.M. Mizuno, C.H. Warden, J.S. Stern, P.J. Havel, Evidence
that glucose metabolism regulates leptin secretion from cul-
tured rat adipocytes, Endocrinology 139 (1998) 551^558.
[46] K. Konopka, E. Pretzer, P.L. Felgner, N. Du«zgu«nes°, Human
immunode¢ciency virus type-1 (HIV-1) infection increases
the sensitivity of macrophages and THP-1 cells to cytotox-
icity by cationic liposomes, Biochim. Biophys. Acta 1312
(1996) 186^196.
[47] R.D. Fields, M.V. Lancaster, Dual-attribute continuous
monitoring of cell proliferation/cytotoxicity, Am. Biotech-
nol. Lab. 11 (1993) 48^50.
[48] L. Vitiello, A. Chonn, J.D. Wasserman, C. Du¡, R.G. Wor-
ton, Condensation of plasmid DNA with polylysine im-
proves liposome-mediated gene transfer into established
and primary muscle cells, Gene Ther. 3 (1996) 396^404.
[49] R.A. Trivedi, G. Dickson, Liposome-mediated gene transfer
into normal and dystrophin de¢cient mouse myoblasts,
J. Neurochem. 64 (1995) 2230^2238.
[50] S. Simo‹es, V. Slepushkin, P. Pires, R. Gaspar, M.C. Pedroso
de Lima, N. Du«zgu«nes°, Mechanism of gene transfer medi-
ated by lipoplexes associated with targeting ligands or pH-
sensitive peptides, Gene Ther. 6 (1999) 1798^1807.
[51] A.V. Kavanov, V.A. Kavanov, DNA complexes with poly-
cations for the delivery of genetic material into cells, Bio-
conjugate Chem. 6 (1995) 7^20.
[52] A.R. Thierry, Y. Lunardi-Iskandar, J.L. Bryant, P. Rabino-
vich, R.C. Gallo, L.C. Mahan, Systemic gene therapy: bio-
distribution and long-term expression of a transgene in mice,
Proc. Natl. Acad. Sci. USA 92 (1995) 9742^9746.
[53] P.N. Reynolds, S.A. Nicklin, L. Kaliberova, B.G. Boatman,
W.E. Grizzle, I.V. Balyasnikova, A.H. Baker, S.M. Danilov,
D.T. Curiel, Combined transductional and transcriptional
targeting improves the speci¢city of transgene expression in
vivo, Nat. Biotechnol. 19 (2001) 838^842.
BBAMEM 78228 26-4-02
C. Tros de Ilarduya et al. / Biochimica et Biophysica Acta 1561 (2002) 209^221 221
